Evidence map›Paper›PMID 30568116›Full record

ArticleInternal medicine (Tokyo, Japan)2019

Metastatic Malignant Lymphoma Mimicking Cerebral Toxoplasmosis with the "Target Sign".

Hiroki Ueno, Kazumi Norose, Teppei Kamimura, Keichiro Mihara, Fumiyuki Yamasaki, Kenji Hikosaka, Vishwa J Amatya, Yukio Takeshima, Kaoru Kurisu, Hirofumi Maruyama

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. MR Target Sign in Cerebral Aspergillosis.The Neurohospitalist · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hiroki UenoDepartment of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Kazumi NoroseDepartment of Infection and Host Defense, Graduate School of Medicine, Chiba University, Japan.
Teppei KamimuraDepartment of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Keichiro MiharaDepartment of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan.
Fumiyuki YamasakiDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Kenji HikosakaDepartment of Infection and Host Defense, Graduate School of Medicine, Chiba University, Japan.
Vishwa J AmatyaDepartment of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Yukio TakeshimaDepartment of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Kaoru KurisuDepartment of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Hirofumi MaruyamaDepartment of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Hiroshima University · JPChiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report the case of a 60-year-old man with a "target sign" in the left frontal lobe on magnetic resonance imaging (MRI), which is thought to be a specific sign of cerebral toxoplasmosis.

Indexed as

BiopsyBrain NeoplasmsHumansLymphoma, Large B-Cell, DiffuseMaleMiddle AgedNeoplasm MetastasisToxoplasmosis, Cerebral18F-FDG PET201Tl-SPECTcerebral toxoplasmosismalignant lymphomaMRItarget sign

Identifiers

PMID30568116
PMCPMC6522404
OpenAlexW2903981339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.